CIK 0001662774 · Non-accelerated filer<br>Smaller reporting company
IRulya Therapeutics Inc.
Sign in to watch- Ticker
- IRLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 901024039
- Phone
- 203-208-8994
- Business address
- 101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
- Former names
- Quince Therapeutics, Inc., Cortexyme, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 69 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-09 | Bonuccelli Catherine M. Director | Grant or award · Director Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2026-11-09 | Valentine James Elwood Director | Grant or award · Director Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2026-11-09 | Wise John Drayton Director | Grant or award · Director Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2026-11-09 | Militello John Chief Financial Officer | Grant or award | +80,000 | 80,000 | ||
| 2026-11-09 | PATTERSON LEONE D Director | Grant or award · Director Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2026-06-11 | Lamond David Director | Grant or award · Director Stock Option (Right to Buy) | +2,700 | 2,700 | ||
| 2026-06-11 | Senner Christopher J. Director | Grant or award · Director Stock Option (Right to Buy) | +2,700 | 2,700 | ||
| 2026-05-18 | Roberts Brigette Chief Corp. Affairs Officer | Grant or award · Employee Stock Option (Right to Buy) | +34,675 | 34,675 | ||
| 2026-05-18 | Roberts Brigette Chief Corp. Affairs Officer | Grant or award · Employee Stock Option (Right to Buy) | +228,855 | 228,855 | ||
| 2026-05-18 | Roberts Brigette Chief Corp. Affairs Officer | Grant or award · Employee Stock Option (Right to Buy) | +124,830 | 124,830 | ||
| 2026-05-18 | Roberts Brigette Chief Corp. Affairs Officer | Grant or award · Employee Stock Option (Right to Buy) | +69,350 | 69,350 | ||
| 2026-05-18 | Roberts Brigette Chief Corp. Affairs Officer | Grant or award · Employee Stock Option (Right to Buy) | +362,092 | 362,092 | ||
| 2026-05-18 | Roberts Brigette Chief Corp. Affairs Officer | Grant or award · Employee Stock Option (Right to Buy) | +133,615 | 133,615 | ||
| 2026-05-18 | Roberts Brigette Chief Corp. Affairs Officer | Grant or award · Employee Stock Option (Right to Buy) | +2,070,107 | 2,070,107 | ||
| 2026-05-18 | Roberts Brigette Chief Corp. Affairs Officer | Grant or award · Employee Stock Option (Right to Buy) | +6,837,319 | 6,837,319 | ||
| 2026-05-18 | Roberts Brigette Chief Corp. Affairs Officer | Grant or award · Employee Stock Option (Right to Buy) | +6,837,319 | 6,837,319 | ||
| 2026-01-23 | Thye Dirk CEO and CMO | Grant or award · Employee Stock Option (Right to Buy) | +1,000,000 | 1,000,000 | ||
| 2026-01-23 | Ryan Charles S. President | Grant or award · Employee Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2026-01-23 | Hannah Brendan CBO, COO & CCO | Grant or award · Employee Stock Option (Right to Buy) | −365,000 | 365,000 | ||
| 2026-01-02 | Senner Christopher J. Director | Grant or award · Director Stock Option (Right to Buy) | +21,810 | 21,810 |
Page 1 of 8 · 152 trades